SNDX - Syndax Pharmaceuticals Inc. (SNDX) CEO Dr. Briggs Morrison on Q4 2020 Results - Earnings Call Transcript
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2020 Results Conference Call March 08, 2021 04:30 PM ET Company Participants Maghan Meyers - Argot Partners Dr. Briggs Morrison - Chief Executive Officer Daphne Karydas - Chief Financial Officer Michael Metzger - President, Chief Operating Officer Dr. Michael Meyers - Chief Medical Officer Dr. Peter Ordentlich - Chief Scientific Officer Conference Call Participants Philip Nadeau - Cowen & Company Bert Hazlett - BTIG Konstantinos Aprilakis - Stifel David Lebowitz - Morgan Stanley Justin Walsh - B. Riley Securities Peter Lawson - Barclays Presentation Operator Good day, everyone, and welcome to the Syndax Fourth Quarter and Full Year 2020 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Ms. Maghan Meyers of Argot Partners. Please begin. Maghan Meyers Welcome, and thank you to those of you joining us on the line and the webcast
For further details see:
Syndax Pharmaceuticals, Inc. (SNDX) CEO Dr. Briggs Morrison on Q4 2020 Results - Earnings Call Transcript